Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy

Journal: Journal of Clinical Investigation

Published: 2020-01-02

DOI: 10.1172/jci127515

Affiliations: 2

Authors: 11

Go to article
Institutions Share
University of Miami (UM), United States of America (USA) 0.50
Sylvester Comprehensive Cancer Center (Sylvester), UM, United States of America (USA) 0.50

Return